Technical Analysis for CRNX - Crinetics Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 16.27 -2.69% -0.45
CRNX closed down 2.69 percent on Friday, September 20, 2019, on 1.81 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CRNX trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Outside Day Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -2.69%
Upper Bollinger Band Touch Strength -5.24%
Shooting Star Candlestick Bearish -7.98%
Lizard Bearish Bearish Day Trade Setup -7.98%
Upper Bollinger Band Touch Strength -7.98%
Crossed Above 20 DMA Bullish -9.31%

Older signals for CRNX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company. The Company is focused on the discovery and development of drugs to treat specialty endocrine diseases and endocrine-related tumors. It develops a pipeline of oral nonpeptide chemical entities that target peptide G protein coupled receptors (GPCRs) for the treatment of endocrine diseases. The Company’s lead product candidate is CRN00808 developed for the treatment of acromegaly. It also develops two other product candidates CRN02481 for hyperinsulinemia, and CRN01941 for the treatment of neuroendocrine tumors. CRN02481 and CRN01941 are both oral nonpeptide somastatin receptors that are in the pre-clinical stages of development. The company also conducts research programs on developing nonpeptide products for the treatment of Cushing’s disease.
Cancer Organ Systems Disease Endocrine System Pancreatic Cancer Acromegaly Neuroendocrinology Endocrine Diseases Neuroendocrine Tumors Stage Pharmaceutical
Is CRNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 36.95
52 Week Low 15.5
Average Volume 71,373
200-Day Moving Average 23.8705
50-Day Moving Average 19.1089
20-Day Moving Average 16.7233
10-Day Moving Average 17.177
Average True Range 1.1363
ADX 20.05
+DI 19.6062
-DI 19.825
Chandelier Exit (Long, 3 ATRs ) 15.8111
Chandelier Exit (Short, 3 ATRs ) 18.9089
Upper Bollinger Band 17.982
Lower Bollinger Band 15.4646
Percent B (%b) 0.32
BandWidth 15.053249
MACD Line -0.5159
MACD Signal Line -0.6824
MACD Histogram 0.1665
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.15
Resistance 3 (R3) 18.30 17.84 17.83
Resistance 2 (R2) 17.84 17.36 17.76 17.73
Resistance 1 (R1) 17.05 17.06 16.82 16.90 17.62
Pivot Point 16.59 16.59 16.47 16.51 16.59
Support 1 (S1) 15.80 16.11 15.57 15.65 14.92
Support 2 (S2) 15.34 15.81 15.26 14.81
Support 3 (S3) 14.55 15.34 14.71
Support 4 (S4) 14.40